Eluvo, a health-tech startup focusing on women in the Philippines, has closed a funding round led by Foxmont Capital Partners.
The transaction details remain undisclosed.
The money will be used to accelerate the growth of the startup’s doctor-led, women-led healthcare clinic in the archipelago, according to a statement.
Also Read: Foxmont secures US$30M in Fund III first close with Grab, DGGF as investors
The Philippines faces several acute systemic healthcare problems, including rising costs, limited specialist availability, and cultural stigmas that frequently deter women from seeking necessary support. The country underperforms against regional peers in nearly all measures of sexual and reproductive health tracked by the UN Population Fund, despite having established regulatory frameworks. Compounding this issue, 46-58 per cent of women report difficulty navigating the conventional healthcare system, highlighting significant structural obstacles.
Eluvo was launched to tackle these issues. It aims to deliver quality, personalised, and stigma-free healthcare across every stage of a woman’s life, integrating clinical expertise, evidence-based diagnostics, and digital access. It offers a modern, personalised, and premium standard of care across fertility care, sexual health, hormone health, family planning, pregnancy & postpartum care, and perimenopause & menopause support.
Eluvo brings “consultations, diagnostics, and treatment together in one location,” supported by omnichannel care and designed to be part of a woman’s lifestyle rather than a sterile medical experience. The approach is encapsulated in the “Talk, Test, Treat model,” an intuitive pathway designed to reframe healthcare as proactive and personalised. This involves compassionate, “stigma-free conversations” led by women-focused providers (Talk); accessible diagnostics through both at-home kits and in-clinic assessments (Test); and evidence-based, tailored treatment plans (Treat).
Strategic partnerships and expansion
To strengthen its leadership in fertility services, Eluvo has established a partnership with GenPrime, a premium fertility clinic with a proven track record across Southeast Asia, China, and the US. This collaboration expands access to “world-class” fertility services by bringing high-end, modern facilities to an underserved market.
The institution is led by Dr Jaycy Olivarez, an OB-GYN who draws on deep personal insight, having undergone IVF herself, providing both professional expertise and an understanding of the patient journey.
Also Read: The most-funded healthtech startups in Southeast Asia: A decade in review
Eluvo has already opened its first clinic in Parqal, Aseana City, offering a safe and empowering environment. Proceeds from the funding round will be channelled into the next phase of growth across Metro Manila. This expansion reflects the company’s commitment to making “top-notch healthcare more widely available” while maintaining the personalised, high standard of care established by the brand.
The post Eluvo raises fresh capital to fix Philippines’s broken women’s healthcare system appeared first on e27.